As continuous monitoring becomes more accessible, technologies originally developed for clinical care may find opportunities far beyond their initial markets
For years, some of the most innovative technologies in healthcare were developed to solve highly specific clinical challenges. Continuous glucose monitoring helped people with diabetes gain a clearer picture of how their bodies responded to treatment. Advanced algorithms supported insulin management. Connected health platforms enabled physicians to monitor patients more effectively between visits.
Companies such as DreaMed emerged from this environment, developing technologies designed to transform continuous streams of health data into practical treatment recommendations. The goal was to help patients and clinicians make better decisions using continuous streams of data.
What is becoming increasingly interesting, however, is that the same capabilities may prove valuable beyond the clinical settings for which they were originally designed. As continuous monitoring expands and consumers gain access to more health data than ever before, the distinctions among disease management, prevention, wellness, performance, and longevity are beginning to blur.
When Clinical Technologies Reach Beyond Healthcare
Wearable devices now provide continuous visibility into heart rate, sleep quality, activity levels, stress indicators, and recovery metrics. Technologies that were once limited to healthcare environments are becoming part of everyday life. Athletes, for example, use glucose data to understand performance; wellness-focused consumers use it to evaluate dietary choices. Individuals interested in healthy aging are exploring how continuous monitoring can provide a deeper understanding of their overall health.
The opportunity is reflected in the numbers. According to the Global Wellness Institute, the global wellness economy reached approximately $6.3 trillion in 2023 and is projected to approach $9 trillion by 2028, driven by growing consumer interest in prevention, personalized health, and healthy aging. At the same time, demand for wearable devices and continuous monitoring technologies continues to expand, creating a much larger audience for platforms that can help translate health data into practical, everyday decisions.
As sensors become more affordable and widespread, health data is becoming increasingly abundant. Yet more data does not automatically lead to better decisions. In fact, the opposite may sometimes be true. Continuous monitoring can generate thousands of data points every week, creating a growing gap between what people can measure and what they can meaningfully interpret.
Technologies developed by companies such as DreaMed were built around a fundamental premise. Continuous monitoring only becomes valuable when it can be translated into actionable guidance. In diabetes care, that guidance may relate to insulin dosing. In other contexts, it could involve nutrition, exercise, recovery, risk reduction, or broader health optimization.
This dynamic – better decisions rather than more data – could create new opportunities for technologies that sit between monitoring and action. As continuous health data becomes increasingly available, the companies best positioned to create value may not necessarily be those building the next sensor, but those helping users make sense of the information they already have.
From Patients to Consumers
None of this guarantees that technologies developed for disease management will successfully transition into broader consumer markets. Healthcare and wellness operate under different economic models, regulatory frameworks, and user expectations.
Still, the direction of travel appears noteworthy. The same forces that once drove adoption of digital tools in chronic disease management – continuous monitoring, personalized insights, and data-driven decision-making – are increasingly influencing how consumers think about their own health.
For digital health companies, this could represent a significant expansion of addressable markets. Technologies initially developed to support patients with specific conditions may eventually find relevance among much larger populations interested in prevention, performance, wellness, and longevity. In some cases, the potential user base may be measured not in millions of patients, but in hundreds of millions of health-conscious consumers.
The broader opportunity may lie in applying proven healthcare innovations to entirely new markets. As the boundaries between healthcare, wellness, and health optimization continue to blur, technologies originally built for disease management may find a much larger audience than they were ever designed to serve.
